The two groups of drugs for Alzheimer's disease that are approved by the U.S. Food and Drug Administration are cholinesterase inhibitors and

Question

Quizplus · Accepted Answer

The two groups of drugs for Alzheimer's disease that are approved by the U.S. Food and Drug Administration are cholinesterase inhibitors and memantine. Cholinesterase inhibitors increase the levels of acetylcholine, a neurotransmitter involved in memory and cognition, while memantine blocks the activity of a neurotransmitter called glutamate, which can damage brain cells in Alzheimer's disease. While other drugs like SSRIs, MAO inhibitors, and lithium may have uses in treating other conditions, they are not approved by the FDA for treating Alzheimer's disease.

The Two Groups of Drugs for Alzheimer's Disease That Are